Browsing Tag
KKR
101 posts
Why KKR is bringing in AWS veteran Adam Selipsky to steer its AI infrastructure strategy
KKR taps former AWS CEO Adam Selipsky as tech and AI advisor—find out how this move could reshape its $179B real assets platform.
Can Karo Healthcare become Europe’s skin health giant after Perrigo’s €120m brand deal?
Karo Healthcare will acquire Perrigo’s €120M skin health brands in Northern Europe. Find out how this move reshapes the consumer healthcare landscape.
Harley-Davidson advances partnership with KKR and PIMCO through $230mn sale of loan receivable interests
Harley-Davidson secures $230mn from sale of loan receivable interests to KKR and PIMCO, reshaping HDFS into a capital-light financing business.
Assura rejects KKR’s advances and backs Primary Health Properties’ £1.8bn takeover offer
Why Assura backed PHP’s £1.79B offer over KKR’s cash bid in a high-stakes UK healthcare real estate battle. Read the full breakdown now.
SupplyHouse secures strategic growth investment from KKR to accelerate U.S. e-commerce expansion
SupplyHouse partners with KKR in a strategic investment to scale HVAC, plumbing, and electrical e-commerce services across the U.S.; experts expect rapid logistics expansion.
Is KKR building a European skincare empire with Perrigo’s dermacosmetics brands?
KKR has agreed to acquire Perrigo’s skincare brands for €327M. Is this the start of a new European skincare empire? Explore the strategy and global implications.
Perrigo to sell dermacosmetics business to KKR-backed Kairos Bidco for up to €327m
Perrigo to sell its dermacosmetics unit to KKR for €327M. See how this streamlines strategy, affects PRGO stock, and refocuses growth priorities.
KKR wins £4.7bn takeover of Spectris, outbidding Advent with premium cash offer
Discover how KKR clinched Spectris for £4.7 billion and why this takeover marks a pivotal moment in UK industrials—read more now!
Torrent Pharmaceuticals to acquire J. B. Chemicals from KKR in INR 25,689 Cr deal: M&A to strengthen CDMO, IPM presence
Torrent Pharmaceuticals to acquire JB Pharma from KKR in INR 25,689 crore deal, followed by merger; aims to expand CDMO and India chronic segment leadership.
Why private equity interest in UK mid-cap takeovers is fading after GlobalData and Craneware
Private equity bids for GlobalData, Craneware, and Darktrace failed amid governance pushback. See why UK mid-cap dealmaking is shifting in 2025.